Sign in
PMVP Stock Price, Chart, Stats & News
PMV Pharmaceuticals, Inc.
Save
PMV Pharmaceuticals, Inc. (PMVP) does not currently pay a dividend.
70.93M
Market cap
–
Current P/E
–
Forward P/E
PMVP chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 2.72% |
ROA | -66.70% |
ROE | -59.07% |
D/E | 0.01x |
Interest coverage ratio | – |
PMVP valuation
P/E | – |
P/S | – |
P/B | 0.67x |
P/CF | -0.95x |
P/FCF | -0.95x |
P/OCF | -0.95x |
PEG | 0.01x |
EV multiple | -1.29x |
About
PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. Their leading experimental drug, PC14586, is a small molecule designed to correct the p53 protein specifically when it contains the Y220C mutation, thereby restoring its natural, functional state. The company is also progressing a pipeline of other programs targeting various mutant p53 forms, including Wild-type p53 Induced-Phosphatase, R282W, R273H, and other prevalent p53 hotspot mutations.
Similar securities
Based on sector and market capitalization
Report issue